medigraphic.com

2020, Número 2

<< Anterior Siguiente >>

Vet Mex 2020; 7 (2)


Detection of mammary adenocarcinoma metastases in a cat through 99mTc-thymine scintigraphy

Castelo BPS, Gutfilen-Schlesinger G, Sena P, Gutfilen-Schlesinger G, Souza SAL, Gutfilen B

Idioma: Español/Inglés
Referencias bibliográficas: 38
Paginas: 1-9
Archivo PDF: 381.73 Kb.


RESUMEN

Sin resumen.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Furian M, Sandei CFCS, Rocha E J N, Lot RFE. Estudo retrospectivo dos tumores mamários em caninos e felinos atendidos no hospital veterinário da famed entre 2003 a 2007. Rev Cient Eletrônica Med Vet. 2007;4(8):1-4.

  2. Daleck CR, Franceschini PH, Alessi AC, Santana AE, Martins MIM. Aspectos clínico e cirúrgico do tumor mamário canino. Cienc Rural. 1998;28:95-100.

  3. Johnston SD. Reproductive systems. In: Slatter D, editor. Textbook of small animal surgery. 2nd ed. Philadelphia: Saunders; 1993. p. 2177-99.

  4. Morrisson WB. Canine and feline mammary tumors. In: Morrisson WB, editor. Cancer in dogs and cats – Medical and surgical management. Baltimore: Williams & Wilkins; 1998. p. 591-8.

  5. dos Santos PCG, Coppieters CC, Barbeiro DAF, Barcelos F. Adenocarcinoma mamário em felinos. Rev Cient Eletrônica Med Vet. 2004;3.

  6. Sorenmo KU, Worley DR, Goldschmidt MH. Tumors of the mammary gland. In: Withrow SJ, Macewen EG, editors. Small animal clinical oncology. 5th ed. Philadelphia: Saunders; 2012. p. 538-52.

  7. Carothers M. Neoplasia respiratória. In: Bichard SJ, Sherding RG, editors. Clínica de pequenos animais. São Paulo: Roca; 1998. p. 663-5.

  8. Morris J. Mammary tumours in the cat: Size matters, so early intervention saves lives. JFMS. 2013;15:391-400

  9. Giménez F. Early detection; aggressive therapy: Optimizing the management of feline mammary masses. JFMS. 2010;12:214-24

  10. Gemignani F, Mayhew PD, Giuffrida MA, Palaigos J, Runge JJ, Holt DE, et al. Association of surgical approach with complication rate, progression-free survival time, and disease-specific survival time in cats with mammary adenocarcinoma: 107 cases (1991-2014). J Am Vet Med Assoc. 2018;252(11):1393-402.

  11. Mattoon JS, Bryan JN. The future of imaging in veterinary oncology: Learning from human medicine. Vet J. 2013;197(3):541-52.

  12. Thrift E, Greenwell C, Turner AL, Harvey AM, Maher D, Malik R. Metastatic pulmonary carcinomas in cats (‘feline lung-digit syndrome’): further variations on a theme. JFMS Open Rep. 2017;3(1).

  13. Aarsvold S, Reetz JA, Reichle JK, Jones ID, Lamb CR, Evola MG, et al. Computed tomographic findings in 57 cats with primary pulmonary neoplasia. Vet Radiol Ultrasound. 2015;56(3):272-7.

  14. Freeman LM. Freeman and Johnson’s Clinical radionuclide imaging. Orlando, FL: Grune and Stratton; 1986. 1528p.

  15. Early P, Sodee B. Principles and practice of nuclear medicine. St Louis, MO: Mosby; 1995.

  16. Menezes ME, Das SK, Minn I, Emdad L, Wang XY, Sarkar D, et al. Detecting tumor metastases: The road to therapy starts here. Adv Cancer Res. 2016;132:1-44.

  17. Gutfilen B, Rodrigues E, Soraggi R, Barbosa Da Fonseca LH. Preliminary observation of 99mTc-thymine imaging in breast neoplasms. Nucl Med Commun. 2001;22(10):1133-7.

  18. Gutfilen B, Fonseca LM. Comparison of Tc-99m THY and Tc-99m MIBI scans for diagnosis of breast lesions. J Exp Clin Cancer Res. 2001;20:385-91.

  19. Ribeiro MP, Souza SA, Lopes FP, Rosado-de-Castro PH, Fonseca LM, Gutfilen B. 99mTc-thymine scintigraphy may be a promising method in the diagnosis of breast cancer. Clinics (Sao Paulo). 2013;68(3):283-9.

  20. Tanigawa N, Morimoto H, Dohmae N, Shimomatsuya T, Takahashi D, Muraoka R. In vitro growth ability and chemosensitivity of gastric and colorectal cancer cells assessed with the human tumor clonogenic assay and thymidine incorporation assay. Eur J Cancer. 1992;28:31-4.

  21. León E, Rey A, Savio E, López J, Kremer E, León A. 99mTc-ADP: agente potencial para la deteccion in vivo de tumores. Rev Esp Med Nuclear. 1993;12:266.

  22. Plotnik DA, Wu S, Linn GR, Yip FCT, Comandante NL, Krohn KA, et al. In vitro analysis of transport and metabolism of 4’-thiothymidine in human tumor cells. Nucl Med Biol. 2015;42(5):470-4.

  23. Vandermeulen E, Combes A, de Rooster H, Polis I, de Spiegeleer B, Saunders J, et al. Transplenic portal scintigraphy using 99mTc-pertechnetate for the diagnosis of portosystemic shunts in cats: a retrospective review of 12 patients. JFMS. 2013;15(12):1123-31.

  24. Pereira CT, Luiz Navarro Marques F, Williams J, Wlademir De Martin B, Primo Bombonato P. 99mTc-labeled dextran for mammary lymphoscintigraphy in dogs. Vet Radiol Ultrasound. 2008;49(5):487-91.

  25. Hayden DW, Nielsen SW. Feline mammary tumours. J Small Anim Practice. 1971;12: 687-98.

  26. Hanh KA, Adams WH. Feline mammary neoplasia: Biological behavior, diagnosis, and treatment alternatives. Feline Oact. 1997;24:5-11.

  27. Hassan BB, Elshafae SM, Supsavhad W, Simmons JK, Dirksen WP, Sokkar SM, et al. Feline mammary cancer. Vet Pathol. 2017 Jan;54(1):32-43. doi: 10.1177/0300985816650243. Epub 2016 Jul 11. PMID: 27281014; PMCID: PMC7212821.

  28. Couto CG, Hammer AS. Oncology. In: Sherding RG, editor. The cat diseases and clinical management. 2nd ed. Philadelphia: Saunders; 1994. p. 755-62.

  29. de Oliveira LO, Rosemari de Oliveira T, Loretti AP, Rodrigues R, Driemeier D. Aspectos epidemiológicos da neoplasia mamária canina. Acta Scientiae Veterinariae. 2003;31(2):105-10.

  30. Lamb CR. The canine and feline lung. In: Thrall DE, editor. Text book of veterinary diagnostic radiology. 4th ed. Philadelphia: Saunders; 2002. p. 431-47.

  31. Morris JS, Nixon C, Bruck A, Nasir L, Morgan IM, Philbey AW. Immunohistochemical expression of TopBP1 in feline mammary neoplasia in relation to histological grade, Ki67, ERAlpha and p53. Vet J. 2008;175:218-26.

  32. Castelo-Branco PSM, de Souza SAL, Lopes FPPL, Castro V, Sena P, Pereira JB, et al. Uso da 99mTc-timina na identificação de metástases de tumor venéreo transmissível canino com apresentação cutânea. Pesq Vet Bras. 2008;28(8):367-70.

  33. Axiak-Bechtel SM, Maitz CA, Selting KA, Bryan JN. Preclinical imaging and treatment of cancer: the use of animal models beyond rodents. Q J Nucl Med Mol Imaging. 2015;59(3):303-16.

  34. Peterson ME, Castellano CA, Rishniw M. Evaluation of body weight, body condition, and muscle condition in cats with hyperthyroidism. J Vet Intern Med. 2016;30(6):1780-9.

  35. Stock E, Vanderperren K, Bosmans T, Dobbeleir A, Duchateau L, Hesta M, et al. Evaluation of feline renal perfusion with contrast-enhanced ultrasonography and scintigraphy. PLoS One. 2016;11(10):e0164488.

  36. Schmitz S, Götte B, Borsch C, Kunz C, Failing K, Neiger R. Direct comparison of solid-phase gastric emptying times assessed by means of a carbon isotope-labeled sodium acetate breath test and technetium Tc-99m albumin colloid radioscintigraphy in healthy cats. Am J Vet Res. 2014;75(7):648-52.

  37. Castelo-Branco PSM, Motta-Silva D, Tancredi MGF, Nazério GCS, Gutfilen B, Fonseca LMB. Uso da cintilografia com 99mtc-Timina na avaliação de mesotelioma em cão: relato de caso. Rev de Ci da Vida. 2006;26 Suppl:391-2.

  38. Baez JL, Sorenmo KU. Pulmonary and bronchial neoplasia. In: King LG, editor. Respiratory disease in dogs and cats. St Louis, MO: Saunders; 2002. p. 508-15.




2020     |     www.medigraphic.com